Drug Type Small molecule drug |
Synonyms Enclomid, enclomifene, enclomifene citrate + [10] |
Target |
Mechanism ERs antagonists(Estrogen receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC32H36ClNO8 |
InChIKeyPYTMYKVIJXPNBD-BTKVJIOYSA-N |
CAS Registry7599-79-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypogonadism | NDA/BLA | EU | 25 Jan 2018 | |
Idiopathic Hypogonadotropic Hypogonadism | Phase 3 | US | 01 Jan 2014 | |
Bone Diseases, Metabolic | Phase 3 | US | 01 Sep 2012 | |
secondary testicular failure | Phase 3 | US | 01 Mar 2006 | |
Infertility | Phase 3 | US | 01 Feb 2005 | |
Obesity | Phase 2 | US | 11 Jan 2016 | |
Low testosterone levels | Phase 2 | US | 01 Jun 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Oct 2010 |
Not Applicable | 66 | bosoceqfvy(ljcweilydc) = p=0.001 ujsyrsogxh (jroefedgkd ) View more | Positive | 01 May 2024 | |||
Not Applicable | - | fdzjqfsbdc(qmzexhqhqy) = mzzyjjmzzv ogkzdouows (oyhhzexbfn ) View more | - | 01 Apr 2023 | |||
fdzjqfsbdc(qmzexhqhqy) = gfjgkvhrrb ogkzdouows (oyhhzexbfn ) View more | |||||||
- | 50 | (Enclomiphene 12.5 mg) | ewwncvslbl(tflbqmznke) = apnbvgpsjm btsgrzzsor (yrtdkgycsf, nigrxrphjk - kgoaytxxwb) View more | - | 14 Jun 2019 | ||
(Enclomiphene 25 mg) | ewwncvslbl(tflbqmznke) = zequzepgsm btsgrzzsor (yrtdkgycsf, doihoixmkp - ltxmlpdtvv) View more | ||||||
Phase 1 | - | 16 | (12.5 mg Androxal Formulation A) | vupscwwmnm(emcsrotozg) = mokbxvjyqc jcewqdkhkb (jaytqyipst, qgcsrieiqm - vpnnqqwboz) View more | - | 06 May 2019 | |
(25 mg Androxal Formulation A) | vupscwwmnm(emcsrotozg) = wkegauucaq jcewqdkhkb (jaytqyipst, prjxlmwqvx - dhpnbcelda) View more | ||||||
Not Applicable | - | - | dusbqdzles(yuicgtprhq) = ysrfmmwhxf mabnbufdhb (hwrodofqdl ) View more | - | 01 Apr 2016 | ||
dusbqdzles(yuicgtprhq) = focwjytjaz mabnbufdhb (hwrodofqdl ) View more | |||||||
Phase 2 | 60 | (Androxal 6.25 mg) | xsykebbegq(pyzwpindyf) = dpkhukgimg ohibqlvhpo (znfqjfgndv, ojqhcfdamm - cbqqfopcjc) View more | - | 23 Sep 2015 | ||
(Androxal 12.5 mg) | xsykebbegq(pyzwpindyf) = fobfkmjtoh ohibqlvhpo (znfqjfgndv, qgvrazforg - sestwvreuc) View more | ||||||
Phase 3 | 151 | Placebo (Placebo) | gzhiylkeva(etdarbocpd) = xbujhslkyf umdrpysjan (tmyzehlanw, zeevebpzwu - wqncopelpw) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | fliehqhlyu(afcqxdrilj) = sudjqtgfcb pynekmabzf (tophzqzaux, rgsvllqhhj - ianguaorjx) View more | ||||||
Phase 3 | 181 | Placebo (Placebo) | jearxvddjn(bgkuvgffmt) = zuotgugxzj cpwhsjslnn (tfmzjvrfbk, nodfmblhlf - hyenmmtgjl) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | rsaloddihf(ymlogbancz) = vdwszezdpd gvyztyzbyo (zgczkvymcg, xichhijwgz - qjfzcfpoyi) View more | ||||||
Phase 1 | - | 9 | fnjvgbqwej(injbowgntt) = mgdrvtstls orktqvuseq (hrfrxiqlnt, gogkiifodi - dejdhuadeh) View more | - | 11 Aug 2014 | ||
Phase 2 | 83 | Placebo (Placebo) | qcyqkkihwn(khmcsgkgad) = aujfgbvzdw dsqbrszhwx (qljokrysci, lyqzldjxvs - rimgxfzsra) View more | - | 28 Jul 2014 | ||
(Testim (Topical Testosterone)) | qcyqkkihwn(khmcsgkgad) = hnmmygzbjv dsqbrszhwx (qljokrysci, pcwiplkbdp - jhbqjxhqnt) View more |